Paper26748629
Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
Satoi S and 13 others. J Hepatobiliary Pancreat Sci, 2016. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial. Papers, record 26748629. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26748629
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Delayed-Action Preparations | Major topic |
| Gastrointestinal Agents | Major topic |
| Non-alcoholic Fatty Liver Disease | Major topic |
| Pancreaticoduodenectomy | Major topic |
| Pancrelipase | Major topic |
| Aged | |
| Aged, 80 and over | |
| Capsules | |
| Case-Control Studies | |
| Cross-Over Studies | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Pancreatic Neoplasms |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42213117 | Effect of reduction in skeletal muscle quantity and sex differences on postoperative hepatic steatosis following total pancreatectomy. | Surg Today | 2026 | https://conductscience.org/library/papers/42213117 | PubMed |
| 41879125 | Incidence and Determinants of Steatotic Liver Disease after Pancreaticoduodenectomy: A Systematic Review and Meta-Analysis. | J Hepatobiliary Pancreat Sci | 2026 | https://conductscience.org/library/papers/41879125 | PubMed |
| 41627580 | Metabolic Dysfunction-Associated Steatotic Liver Disease after Pancreatoduodenectomy: an Underestimated Metabolic Complication Driven by Unique Pathophysiological Mechanisms. | J Gastrointest Cancer | 2026 | https://conductscience.org/library/papers/41627580 | PubMed |
| 41194053 | Postoperative supplementation with high-titer pancreatic enzymes and zinc acetate dihydrate could reduce the risk of liver fat deposition, especially in patients with severe remnant pancreatic atrophy after pancreaticoduodenectomy: a retrospective study. | BMC Surg | 2025 | https://conductscience.org/library/papers/41194053 | PubMed |
| 40500466 | Clinical outcomes of pancrelipase administration after pancreaticoduodenectomy. | Surg Today | 2025 | https://conductscience.org/library/papers/40500466 | PubMed |
| 38919271 | Are transmembrane 6 superfamily member 2 gene polymorphisms associated with steatohepatitis after pancreaticoduodenectomy? | JGH Open | 2024 | https://conductscience.org/library/papers/38919271 | PubMed |
| 38581555 | Radiomics-based prediction of nonalcoholic fatty liver disease following pancreatoduodenectomy. | Surg Today | 2024 | https://conductscience.org/library/papers/38581555 | PubMed |
| 37975040 | Hepatic Steatosis After Partial Pancreatectomy in a Cohort of Patients with Intraductal Papillary Mucinous Neoplasm. | J Clin Exp Hepatol | 2023 | https://conductscience.org/library/papers/37975040 | PubMed |
| 37486541 | A case of steatohepatitis that developed after pancreaticoduodenectomy and progressed rapidly to liver cirrhosis and hepatocellular carcinoma. | Clin J Gastroenterol | 2023 | https://conductscience.org/library/papers/37486541 | PubMed |
| 36902534 | Perioperative Drug Treatment in Pancreatic Surgery-A Systematic Review and Meta-Analysis. | J Clin Med | 2023 | https://conductscience.org/library/papers/36902534 | PubMed |
| 36338591 | Significant positive impact of duodenum-preserving pancreatic head resection on the prevention of postoperative nonalcoholic fatty liver disease and acute cholangitis. | Ann Gastroenterol Surg | 2022 | https://conductscience.org/library/papers/36338591 | PubMed |
| 35381910 | Nonalcoholic fatty liver disease developed after pancreatoduodenectomy for solid pseudopapillary neoplasm in a 10-year-old girl: a case report. | Surg Case Rep | 2022 | https://conductscience.org/library/papers/35381910 | PubMed |
| 31463596 | Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients undergoing pancreaticoduodenectomy. | Surg Today | 2020 | https://conductscience.org/library/papers/31463596 | PubMed |
| 30218781 | Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm. | Int J Surg | 2018 | https://conductscience.org/library/papers/30218781 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26748629
GET https://conductscience.org/api/papers/v1/26748629/authors